TTrialPathMatch Me to Trials
← Back to trials
RecruitingCirrhosis, LiverDiabetes Mellitus RiskTransplant; Failure, Liver

Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant

Eligible age

18–75 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced measurements such as wrist actigraphy, continuous glucose monitoring, or oral glucose tolerance testing predict the development of diabetes after liver transplant? Participants will be asked to periodically participate in wearing a continuous glucose monitor and wrist actigraph and obtain an oral glucose tolerance test both before and after liver transplant.

Sponsor: University of Chicago

You may qualify if…

  • Patients presenting to liver transplant clinic with a diagnosis of cirrhosis.
  • Age \>18 yrs.
  • Ability to understand and sign written consent form, or have a legally-authorized representative or proxy who can be approached for consent

You may not qualify if…

  • Patients without consent
  • Patients with implantable cardioverter defibrillator devices or automated implantable cardioverter defibrillator devices will be excluded from the bio-electrical impedance analysis portion of the measurements.
  • Patients with unremovable electrical medical devices or devices that cannot turn off will be excluded from the bio-electrical impedance analysis measurements
  • Pregnant patients
  • Incarcerated patients
  • Patients with a history of type 2 diabetes mellitus diagnosed \> 5 years ago will be excluded from the Oral Glucose Tolerance Test portion of the study

Where it's recruiting

Illinois

Chicago

Source: ClinicalTrials.gov · NCT06950788 · last updated 2026-05-07